FONAR (NASDAQ:FONR – Get Free Report) posted its quarterly earnings results on Wednesday. The medical equipment provider reported $0.29 EPS for the quarter, Zacks reports. The company had revenue of $24.95 million for the quarter. FONAR had a net margin of 9.41% and a return on equity of 6.10%.
FONAR Trading Down 0.1 %
Shares of FONR stock opened at $15.04 on Thursday. FONAR has a twelve month low of $14.05 and a twelve month high of $24.05. The stock has a fifty day simple moving average of $15.48 and a two-hundred day simple moving average of $15.96. The stock has a market capitalization of $95.20 million, a price-to-earnings ratio of 10.74 and a beta of 1.23.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered shares of FONAR from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 16th.
FONAR Company Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Read More
- Five stocks we like better than FONAR
- Financial Services Stocks Investing
- Should You Hold Nvidia Stock for the Long Haul or Trade It?
- Canada Bond Market Holiday: How to Invest and Trade
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.
